NIH-funded research R21 grant

Understanding the brain's circadian clock and its components

Official title: BMAL1 Circadian Clock Complexes from Mammalian Brain

Funded at Harvard Medical School · NIH-11056939 · Data updated 2026-11-12

This study looks at how a specific protein in the brain helps control our daily body rhythms, which could help us understand how problems with these rhythms might affect conditions like bipolar disorder.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionHarvard Medical School
NIH-funded
Lab location1 site (Boston, United States)
Project startSeptember 19, 2024
Project endAugust 31, 2026
Funding year2024
Award (this year)$466,125
NIH project number1R21NS136974-01A1
Project IDNIH-11056939 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit include individuals with mood disorders, particularly those experiencing bipolar disorder or other affective disorders.

Less likely to help

Patients without any mood disorders or those not affected by circadian rhythm disruptions may not receive benefit from this research.

What this research studies

This research investigates the molecular mechanisms of the circadian clock in the mammalian brain, focusing on the role of the BMAL1 transcription factor. By purifying and studying BMAL1 complexes from brain tissue, the research aims to uncover how these complexes regulate daily biological rhythms. The approach involves biochemical and structural analyses to understand the interactions and functions of BMAL1 in maintaining circadian rhythms. Patients may benefit from insights into how disruptions in these rhythms could affect conditions like bipolar disorder.

Why it matters

Potential benefit: If successful, this research could lead to new treatments for mood disorders by targeting circadian rhythm disruptions.

How similar studies have gone: Previous research has shown promising results in understanding circadian rhythms and their impact on mood disorders, indicating that this approach has potential for success.

Where this research is happening

  • Harvard Medical School
    Boston, United States
    Active

Researchers

  • Principal investigator: Weitz, Charles J — Harvard Medical School
  • Study coordinator: Weitz, Charles J

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.